Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis
- 7 May 2010
- journal article
- review article
- Published by Elsevier
- Vol. 1801 (8) , 878-886
- https://doi.org/10.1016/j.bbalip.2010.05.003
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Nerve Growth Factor-induced Glutamate Release Is via p75 Receptor, Ceramide, and Ca2+ from Ryanodine Receptor in Developing Cerebellar NeuronsJournal of Biological Chemistry, 2003
- Ceramide Stabilizes β-Site Amyloid Precursor Protein-cleaving Enzyme 1 and Promotes Amyloid β-Peptide BiogenesisJournal of Biological Chemistry, 2003
- The role of glutathione, membrane sphingomyelin, and its metabolites in oxidative stress-induced calcium “dysregulation” in PC12 cellsFree Radical Biology & Medicine, 1999
- Ceramide signalling and the immune responseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Ceramide Prevents Neuronal Programmed Cell Death Induced by Nerve Growth Factor DeprivationJournal of Neurochemistry, 1995
- Gangliosides -- A new therapeutic agent against stroke and Alzheimer's diseaseLife Sciences, 1994
- Age‐Related Changes in the Ceramide Composition of the Major Gangliosides Present in Rat Brain Subcellular Fractions Enriched in Plasma Membranes of Neuronal and Myelin OriginJournal of Neurochemistry, 1993
- Cortical distribution of gangliosides in Alzheimer's diseaseNeurochemistry International, 1992
- The presence of sphingomyelin- and ceramide-cleaving enzymes in the small intestinal tractBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1969